Radiographic resolution of chronic rhinosinusitis without polyposis after 6 weeks vs 3 weeks of oral antibiotics

Annals of Allergy, Asthma and Immunology

Volumn 98, Issue 1, 2007, Pages 32-35

  Dubin, Marc G ^a,d   Kuhn, Frederick A ^b,c   Melroy, Christopher T ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Georgia Nasal and Sinus Institute   (United States)

^d Physicians Pavilion East   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CLAVULANIC ACID; CLINDAMYCIN; DOXYCYCLINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; STEROID;

ADULT; ANTIBIOTIC THERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DRUG HYPERSENSITIVITY; ENTEROCOLITIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHINOSINUSITIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33846259331     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60856-3     Document Type: Article

References (15)

1. Lund VJ. Maximal medical therapy for chronic rhinosinusitis. Otolaryngol Clin North Am. 2005;38:1301-1310.
2. McNally PA, White MV, Kaliner MA. Sinusitis in an allergist's office: analysis of 200 consecutive cases. Allergy Asthma Proc. 1997;18:169-175.
3. Subramanian HN, Schechtman KB, Hamilos DL. A retrospective analysis of treatment outcomes and time to relapse after intensive medical treatment for chronic sinusitis. Am J Rhinol. 2002;16:303-312.
4. Piccirillo JF, Edwards D, Haiduk A, et al. Psychometric and clinimetric validity of the 31-item rhinosinusitis outcome measure (RSOM-31). Am J Rhinol. 1995;297-306.
5. Lund VJ, Kennedy DW. Staging tor rhinosinusitis. Otolaryngol Head Neck Surg. 1997;117:535-40.
6. Dubin MG, Ebert CS, Coffey CS, et al. Concordance of middle meatal swab and maxillary sinus aspirate in acute and chronic sinusitis: a meta-analysis. Am J Rhinol. 2005;19:462-470.
7. Brook I. Microbiology and antimicrobial management of sinusitis. J Laryngol Otol. 2005;119:251-258.
8. Brook I, Frazier EH, Foote PA. Microbiology of the transition from acute to chronic maxillary sinusitis. J Med Microbiol. 1996;45:372-375.
9. Legent F, Bordure P, Beauvillain C, et al. A double-blind comparison of ciprofloxacin and amoxycillin/clavulanic acid in the treatment of chronic sinusitis. Chemotherapy. 1994; 40(suppl 1):8-15.
10. Namyslowski G, Misiolek M, Czecior E, et al. Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults. J Chemother. 2002;14:508-517.
11. Anand V, Levine H, Friedman M, et al. Intravenous antibiotics for refractory rhinosinusitis in nonsurgical patients: preliminary findings of a prospective study. Am J Rhinol. 2003;17:363-368.
12. Don DM, Yellon RF, Casselbrant ML, et al. Efficacy of a stepwise protocol that includes intravenous antibiotic therapy for the management of chronic sinusitis in children and adolescents. Arch Otolaryngol Head Neck Surg. 2001;127:1093-1098.
13. Spector SL, Bernstein IL, Li JT, et al. Parameters for the diagnosis and management of sinusitis. J Allergy Clin Immunol. 1998;102:S107-44.
14. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114:155-212.
15. Hamilos DL, Lanza DC, Kennedy DW. Rhinosinusitis and the revised "sinusitis practice parameters". J Allergy Clin Immunol. 2005;116:1267-1268.